Page 27 - Interim Chief News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Retrospective analysis of patients with myelodysplastic syndromes showed trends in treatment patterns that suggest: improved trend persistence with oral decitabine and cedazuridine versus intravenous/subcutaneous hypomethylating agents beyond 6 months comparable persistence between oral decitabine and cedazuridine and intravenous/subcutaneous hypomethylating agents at early stages of therapy PRINCETON, N.J., Dec. 10, 2023 /PRNewswire/ — Taiho Oncology, Inc. announced […]

The City of Sedalia announced an organizational change last week, with half of the departments reporting to City Administrator Kelvin Shaw, and the other half reporting to his new assistant City Administrator Matt Wirt.

/PRNewswire/ -- Taiho Oncology, Inc. announced results of a U.S. real-world study of oral decitabine and cedazuridine (DEC-C) in patients with myelodysplastic...

Wednesday, December 06, 2023 – Texas police have arrested a gunman who allegedly went on a violent city-wide shooting spree, killing 6 people and injuring three more — including two police officers — on Tuesday, Dec. 5. The male suspect was arrested and charged with Capital Murder of Multiple Persons late Tuesday night, the Austin Police…

Chief Dale McDorman is leaving on the heels of department accreditation. Deputy Chief Price will take over during the search for a new chief